Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2016

01-08-2016 | Images in Nephrology

Toxic epidermal necrolysis due to cyclophosphamide

Authors: Gulsah Sasak, Ebru Zemheri, Abdullah Ozkok

Published in: Clinical and Experimental Nephrology | Issue 4/2016

Login to get access

Excerpt

A 63-year-old-male was admitted with rapidly progressive glomerulonephritis (RPGN) and diagnosed as microscopic polyangiitis. Pulse methylprednisolone (MP) (total 3 g) and intravenous cyclophosphamide (CYC) 500 mg were started. After 2 weeks, diffuse erythema, mucocutaneous tenderness and blisters developed and within a week epidermal detachments were apparent (Fig. 1). Involvement of the mucosa occurred with oral aphthous ulcers and conjunctivitis.
Literature
1.
go back to reference Assier-Bonnet H, Aractingi S, Cadranel J, Wechsler J, Mayaud C, Saiag P. Stevens–Johnson syndrome induced by cyclophosphamide: report of two cases. Br J Dermatol. 1996;135(5):864–6.CrossRefPubMed Assier-Bonnet H, Aractingi S, Cadranel J, Wechsler J, Mayaud C, Saiag P. Stevens–Johnson syndrome induced by cyclophosphamide: report of two cases. Br J Dermatol. 1996;135(5):864–6.CrossRefPubMed
2.
Metadata
Title
Toxic epidermal necrolysis due to cyclophosphamide
Authors
Gulsah Sasak
Ebru Zemheri
Abdullah Ozkok
Publication date
01-08-2016
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2016
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-015-1181-4

Other articles of this Issue 4/2016

Clinical and Experimental Nephrology 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.